Caption Management, LLC Deciphera Pharmaceuticals, Inc. Transaction History

Caption Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$6.87 - $11.11 $171,750 - $277,750	-25,000 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$7.7 - $37.13 $4,643 - $22,389	-603 Reduced 2.36%	25,000 $244,000
Q3 2021 Nov 12, 2021	SELL	$26.46 - $37.15 $182,494 - $256,223	-6,897 Reduced 21.22%	25,603 $870,000
Q2 2021 Aug 16, 2021	BUY	$32.73 - $47.95 $700,421 - $1.03 Million	21,400 Added 192.79%	32,500 $1.19 Million
Q1 2021 May 17, 2021	SELL	$40.39 - $56.73 $1.16 Million - $1.63 Million	-28,800 Reduced 72.18%	11,100 $498,000
Q4 2019 Feb 13, 2020	BUY	$31.7 - $69.93 $1.26 Million - $2.79 Million	39,900 New	39,900 $2.48 Million

343K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.